Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (446)	6/15/1999 11:17:00 PM
From: John Dwyer	Respond to of 3158

Why don't you guys come to Chicago and we can listen to _you_ bitch about being in Chicago... Congrats to Rick, MZ, etc on the Sugen munch! Also of note today... Novalon's deal with Axys and Aurora's deal with Pfizer. Quite a day! John

To: scaram(o)uche who wrote (446)	6/16/1999 12:36:00 AM
From: Vector1	Read Replies (1) \| Respond to of 3158

Rick, MZ, Peter and others congrats on SUGN. I wish I was in. I believe this acquisition will have a bigger impact on the sector than WLA's purchase of AGPH. This deal proves that big Pharma is interested in relatively early stage biotechs. The universe of companies that may be acquired IMO has expanded. This is great for the sector and I think we will will begin to see a major rally in smaller biotechs. Indeed in addition to GNE I know of two other biothechs that have public offerings planned over the next few weeks. If they get done the tide has turned. It's about time. Ok, What company is next. At current levels is SEPR a target? How about GLFD. CELG V1